Posted by Michael Wonder on 15 Jul 2025
New cystic fibrosis drug fast tracked for NHS use
15 July 2025 - Some people with cystic fibrosis are set to benefit from a new once daily triple therapy treatment, following NICE's recommendation of Alyftrek in final draft guidance published today.
The treatment will be available for patients aged 6 years and over who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator gene, representing approximately 89% of people with the condition in England.
